Using the slit guidance ligand 2 (SLIT2)‐trapping protein Robo1Fc effectively inhibits macrophage infiltration and tumor growth in GBM mouse models, significantly improving the antitumor effects by its combination with anti‐PD‐1 and anti‐4‐1BB therapies [282]. The gene discussed is SNCA; the disease is glioblastoma.